APRIL limits atherosclerosis by binding to heparan sulfate proteoglycans
Dimitrios Tsiantoulas, Mahya Eslami, Georg Obermayer, Marc Clément, Diede Smeets, Florian Mayer, Máté G. Kiss, Lennart Enders, Juliane Weißer, Laura Göderle, Jordi Lambert, Florian Frommlet, André C. Müller, Tim Hendrikx, Mária Ozsvár-Kozma, Florentina Porsch, Laure Willen, Taras Afonyushkin, Jane E. Murphy, Per Fogelstrand, Olivier Donzé, Gerard Pasterkamp, Matthias Hoke, Stefan Kubicek, Helle F. Jørgensen, Nicolas Danchin, Tabassome Simon, Hubert Scharnagl, Winfried März, Jan Borén, Henry Hess, Ziad Mallat, Pascal Schneider, Christoph J. Binder
Topics & Concepts
PerlecanHeparan sulfateProteoglycanHomeostasisAntibodyInflammationChemistryExtracellular matrixCell biologyImmunologyBiochemistryMedicineBiologyInternal medicineGlycosaminoglycanProteoglycans and glycosaminoglycans researchCell Adhesion Molecules ResearchCaveolin-1 and cellular processes